Iterum Therapeutics plc (ITRM)

Iterum Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	27	26	10	72	43	67	71
Market Cap Growth	-	150.18%	-85.65%	68.25%	-36.39%	-5.68%	-
Enterprise Value	22	21	-22	17	70	76	0
PE Ratio	-0.67	-0.67	-0.23	-0.78	-0.82	-0.65	-0.92
PS Ratio	-	-	-	-	-	1808.39	81.63
PB Ratio	-4.01	-4.01	0.37	1.43	-0.84	-2.55	0.99
P/FCF Ratio	-0.65	-0.65	-0.55	-4.50	-0.78	-0.82	-0.92
P/OCF Ratio	-0.65	-0.65	-0.56	-4.52	-0.78	-0.82	-0.92
EV/Sales Ratio	-	-	-	-	-	2040.66	0.52
EV/EBITDA Ratio	-0.60	-0.60	0.55	-0.20	-1.95	-0.74	-0.01
EV/EBIT Ratio	-0.57	-0.57	0.53	-0.20	-1.94	-0.74	-0.01
EV/FCF Ratio	-0.53	-0.53	1.19	-1.05	-1.29	-0.92	-0.01
Debt / Equity Ratio	-2.96	-2.96	1.02	0.53	-0.84	-0.51	0.20
Debt / EBITDA Ratio	-0.55	-0.55	-0.71	-0.32	-1.18	-0.13	-0.19
Debt / FCF Ratio	-0.48	-0.48	-1.54	-1.67	-0.78	-0.16	-0.18
Quick Ratio	1.77	1.77	6.71	6.29	0.35	0.13	6.92
Current Ratio	1.89	1.89	6.89	6.43	0.52	0.32	7.61
Asset Turnover	0	0	0	0	0	0.00	0.01
Interest Coverage	-25.44	-25.44	-17.69	-15.36	-2.40	-118.26	-178.77
Return on Equity (ROE)	-664.00%	-664.00%	-116.10%	-201.90%	105.60%	-880.10%	-89.60%
Return on Assets (ROA)	-87.60%	-87.60%	-59.40%	-89.10%	-156.30%	-174.00%	-72.00%
Return on Capital (ROIC)	-378.14%	-378.14%	-53.81%	-31.97%	390.83%	796.23%	-89.31%
Earnings Yield	-139.87%	-149.25%	-432.40%	-127.86%	-122.19%	-154.13%	-108.62%
FCF Yield	-143.42%	-153.03%	-180.37%	-22.21%	-128.14%	-122.47%	-109.03%
Buyback Yield / Dilution	-5.93%	-5.93%	-12.35%	-580.42%	-65.38%	-66.22%	-4974.28%
Total Shareholder Return	-5.93%	-5.93%	-12.35%	-580.42%	-65.38%	-66.22%	-4974.28%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).